APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artemether

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Artemether Market Outlook and Growth Opportunities 2026

26 December 2025198 pages

Choose your research edition.

Industry ResearchArtemether Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Artemether Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Artemether Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artemether Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Artemether Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Artemether market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Artemether is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Artemether is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Artemether is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Artemether market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Artemether market include Ankang ChiaTai Pharmaceutical, Guangzhou Hanfang Pharmaceutical, Shreeji Pharma International, KPC Pharmaceuticals and HOFON, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Artemether market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Artemether and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artemether sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Artemether market size, projected growth trends, production technologies, key applications, and end-use industries.

Artemether Segment by Company

Ankang ChiaTai Pharmaceutical

Guangzhou Hanfang Pharmaceutical

Shreeji Pharma International

KPC Pharmaceuticals

HOFON

Artemether Segment by Type

Capsules Artemether

Tablets Artemether

Injectables Artemether

Artemether Segment by Application

Clinic

Hospital

Laboratory

Others

Artemether Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Artemether status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Artemether market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Artemether significant trends, drivers, influence factors in global and regions.

6. To analyze Artemether competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artemether market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artemether and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artemether.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Artemether market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artemether industry.

Chapter 3: Detailed analysis of Artemether manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Artemether in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Artemether in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Artemether Industry Trends Table 2. Artemether Industry Drivers Table 3. Artemether Industry Opportunities and Challenges Table 4. Artemether Industry Restraints Table 5. Global Artemether Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Artemether Revenue Share by Company (2021-2026) Table 7. Global Artemether Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Artemether Sales Volume Share by Company (2021-2026) Table 9. Global Artemether Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Artemether Company Ranking, (2024-2026) & (USD Million) Table 11. Global Artemether Key Company Manufacturing Base & Headquarters Table 12. Global Artemether Company, Product Type & Application Table 13. Global Artemether Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Artemether by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Capsules Artemether Table 18. Significant Companies of Tablets Artemether Table 19. Significant Companies of Injectables Artemether Table 20. Global Artemether Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Artemether Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Artemether Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Artemether Sales Volume Share by Type (2021-2026) Table 24. Global Artemether Sales Volume Share by Type (2027-2032) Table 25. Global Artemether Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Artemether Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Artemether Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Artemether Sales Value Share by Type (2021-2026) Table 29. Global Artemether Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Clinic Table 31. Significant Companies of Hospital Table 32. Significant Companies of Laboratory Table 33. Significant Companies of Others Table 34. Global Artemether Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Artemether Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Artemether Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Artemether Sales Volume Share by Application (2021-2026) Table 38. Global Artemether Sales Volume Share by Application (2027-2032) Table 39. Global Artemether Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Artemether Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Artemether Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Artemether Sales Value Share by Application (2021-2026) Table 43. Global Artemether Sales Value Share by Application (2027-2032) Table 44. Global Artemether Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Artemether Sales by Region (2021-2026) & (K Units) Table 46. Global Artemether Sales Market Share by Region (2021-2026) Table 47. Global Artemether Sales by Region (2027-2032) & (K Units) Table 48. Global Artemether Sales Market Share by Region (2027-2032) Table 49. Global Artemether Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Artemether Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Artemether Sales Value Share by Region (2021-2026) Table 52. Global Artemether Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Artemether Sales Value Share by Region (2027-2032) Table 54. Global Artemether Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Artemether Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Artemether Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Artemether Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Artemether Sales by Country (2021-2026) & (K Units) Table 59. Global Artemether Sales Market Share by Country (2021-2026) Table 60. Global Artemether Sales by Country (2027-2032) & (K Units) Table 61. Global Artemether Sales Market Share by Country (2027-2032) Table 62. Global Artemether Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Artemether Sales Value Market Share by Country (2021-2026) Table 64. Global Artemether Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Artemether Sales Value Market Share by Country (2027-2032) Table 66. Ankang ChiaTai Pharmaceutical Company Information Table 67. Ankang ChiaTai Pharmaceutical Business Overview Table 68. Ankang ChiaTai Pharmaceutical Artemether Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Ankang ChiaTai Pharmaceutical Artemether Product Portfolio Table 70. Ankang ChiaTai Pharmaceutical Recent Development Table 71. Guangzhou Hanfang Pharmaceutical Company Information Table 72. Guangzhou Hanfang Pharmaceutical Business Overview Table 73. Guangzhou Hanfang Pharmaceutical Artemether Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Guangzhou Hanfang Pharmaceutical Artemether Product Portfolio Table 75. Guangzhou Hanfang Pharmaceutical Recent Development Table 76. Shreeji Pharma International Company Information Table 77. Shreeji Pharma International Business Overview Table 78. Shreeji Pharma International Artemether Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Shreeji Pharma International Artemether Product Portfolio Table 80. Shreeji Pharma International Recent Development Table 81. KPC Pharmaceuticals Company Information Table 82. KPC Pharmaceuticals Business Overview Table 83. KPC Pharmaceuticals Artemether Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. KPC Pharmaceuticals Artemether Product Portfolio Table 85. KPC Pharmaceuticals Recent Development Table 86. HOFON Company Information Table 87. HOFON Business Overview Table 88. HOFON Artemether Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. HOFON Artemether Product Portfolio Table 90. HOFON Recent Development Table 91. Key Raw Materials Table 92. Raw Materials Key Suppliers Table 93. Artemether Distributors List Table 94. Artemether Customers List Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Artemether Product Image Figure 2. Global Artemether Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artemether Sales Value (2021-2032) & (US$ Million) Figure 4. Global Artemether Sales (2021-2032) & (K Units) Figure 5. Global Artemether Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Artemether Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Capsules Artemether Image Figure 10. Tablets Artemether Image Figure 11. Injectables Artemether Image Figure 12. Global Artemether Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Artemether Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Artemether Sales Volume Share by Type (2021-2032) Figure 15. Global Artemether Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Artemether Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Artemether Sales Value Share by Type (2021-2032) Figure 18. Clinic Image Figure 19. Hospital Image Figure 20. Laboratory Image Figure 21. Others Image Figure 22. Global Artemether Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Artemether Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Artemether Sales Volume Share by Application (2021-2032) Figure 25. Global Artemether Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Artemether Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Artemether Sales Value Share by Application (2021-2032) Figure 28. Global Artemether Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Artemether Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Artemether Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Artemether Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Artemether Sales Value (2021-2032) & (US$ Million) Figure 33. North America Artemether Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Artemether Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Artemether Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Artemether Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Artemether Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Artemether Sales Value (2021-2032) & (US$ Million) Figure 39. South America Artemether Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Artemether Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Artemether Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Artemether Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Artemether Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Artemether Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Artemether Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Artemether Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules Artemether
  • Tablets Artemether
  • Injectables Artemether
Applications
  • Clinic
  • Hospital
  • Laboratory
  • Others
Companies covered
  • Ankang ChiaTai Pharmaceutical
  • Guangzhou Hanfang Pharmaceutical
  • Shreeji Pharma International
  • KPC Pharmaceuticals
  • HOFON

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Artemether Sales Value (2021-2032)
  4. 1.2.2 Global Artemether Sales Volume (2021-2032)
  5. 1.2.3 Global Artemether Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Artemether Market Dynamics
  1. 2.1 Artemether Industry Trends
  2. 2.2 Artemether Industry Drivers
  3. 2.3 Artemether Industry Opportunities and Challenges
  4. 2.4 Artemether Industry Restraints
3 Artemether Market by Company
  1. 3.1 Global Artemether Company Revenue Ranking in 2025
  2. 3.2 Global Artemether Revenue by Company (2021-2026)
  3. 3.3 Global Artemether Sales Volume by Company (2021-2026)
  4. 3.4 Global Artemether Average Price by Company (2021-2026)
  5. 3.5 Global Artemether Company Ranking (2024-2026)
  6. 3.6 Global Artemether Company Manufacturing Base and Headquarters
  7. 3.7 Global Artemether Company Product Type and Application
  8. 3.8 Global Artemether Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Artemether Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Artemether Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Artemether Market by Type
  1. 4.1 Artemether Type Introduction
  2. 4.1.1 Capsules Artemether
  3. 4.1.2 Tablets Artemether
  4. 4.1.3 Injectables Artemether
  5. 4.2 Global Artemether Sales Volume by Type
  6. 4.2.1 Global Artemether Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Artemether Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Artemether Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Artemether Sales Value by Type
  10. 4.3.1 Global Artemether Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Artemether Sales Value by Type (2021-2032)
  12. 4.3.3 Global Artemether Sales Value Share by Type (2021-2032)
5 Artemether Market by Application
  1. 5.1 Artemether Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Laboratory
  5. 5.1.4 Others
  6. 5.2 Global Artemether Sales Volume by Application
  7. 5.2.1 Global Artemether Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Artemether Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Artemether Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Artemether Sales Value by Application
  11. 5.3.1 Global Artemether Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Artemether Sales Value by Application (2021-2032)
  13. 5.3.3 Global Artemether Sales Value Share by Application (2021-2032)
6 Artemether Regional Sales and Value Analysis
  1. 6.1 Global Artemether Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Artemether Sales by Region (2021-2032)
  3. 6.2.1 Global Artemether Sales by Region: 2021-2026
  4. 6.2.2 Global Artemether Sales by Region (2027-2032)
  5. 6.3 Global Artemether Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Artemether Sales Value by Region (2021-2032)
  7. 6.4.1 Global Artemether Sales Value by Region: 2021-2026
  8. 6.4.2 Global Artemether Sales Value by Region (2027-2032)
  9. 6.5 Global Artemether Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Artemether Sales Value (2021-2032)
  12. 6.6.2 North America Artemether Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Artemether Sales Value (2021-2032)
  15. 6.7.2 Europe Artemether Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Artemether Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Artemether Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Artemether Sales Value (2021-2032)
  21. 6.9.2 South America Artemether Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Artemether Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Artemether Sales Value Share by Country, 2025 VS 2032
7 Artemether Country-level Sales and Value Analysis
  1. 7.1 Global Artemether Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Artemether Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Artemether Sales by Country (2021-2032)
  4. 7.3.1 Global Artemether Sales by Country (2021-2026)
  5. 7.3.2 Global Artemether Sales by Country (2027-2032)
  6. 7.4 Global Artemether Sales Value by Country (2021-2032)
  7. 7.4.1 Global Artemether Sales Value by Country (2021-2026)
  8. 7.4.2 Global Artemether Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Artemether Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Artemether Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Artemether Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Artemether Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Artemether Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Artemether Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Artemether Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Artemether Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Artemether Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Artemether Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Artemether Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Artemether Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Artemether Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Artemether Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Artemether Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Artemether Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Artemether Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Artemether Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Artemether Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Artemether Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Artemether Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Artemether Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Artemether Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Artemether Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Artemether Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Artemether Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Artemether Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Artemether Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Artemether Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Artemether Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Artemether Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Artemether Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Artemether Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Artemether Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Artemether Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Artemether Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Artemether Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Artemether Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Artemether Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Artemether Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Artemether Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Artemether Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Artemether Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Artemether Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Artemether Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Artemether Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Artemether Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Artemether Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Artemether Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Artemether Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Artemether Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Artemether Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Artemether Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Artemether Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Artemether Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Artemether Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Artemether Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Artemether Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Artemether Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Artemether Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Artemether Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Artemether Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Artemether Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Artemether Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Artemether Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Artemether Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Artemether Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Artemether Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Artemether Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Artemether Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Artemether Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Artemether Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Artemether Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Artemether Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Artemether Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Artemether Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Artemether Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Artemether Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Artemether Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Artemether Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Artemether Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Artemether Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Artemether Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Artemether Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ankang ChiaTai Pharmaceutical
  2. 8.1.1 Ankang ChiaTai Pharmaceutical Company Information
  3. 8.1.2 Ankang ChiaTai Pharmaceutical Business Overview
  4. 8.1.3 Ankang ChiaTai Pharmaceutical Artemether Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Ankang ChiaTai Pharmaceutical Artemether Product Portfolio
  6. 8.1.5 Ankang ChiaTai Pharmaceutical Recent Developments
  7. 8.2 Guangzhou Hanfang Pharmaceutical
  8. 8.2.1 Guangzhou Hanfang Pharmaceutical Company Information
  9. 8.2.2 Guangzhou Hanfang Pharmaceutical Business Overview
  10. 8.2.3 Guangzhou Hanfang Pharmaceutical Artemether Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Guangzhou Hanfang Pharmaceutical Artemether Product Portfolio
  12. 8.2.5 Guangzhou Hanfang Pharmaceutical Recent Developments
  13. 8.3 Shreeji Pharma International
  14. 8.3.1 Shreeji Pharma International Company Information
  15. 8.3.2 Shreeji Pharma International Business Overview
  16. 8.3.3 Shreeji Pharma International Artemether Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shreeji Pharma International Artemether Product Portfolio
  18. 8.3.5 Shreeji Pharma International Recent Developments
  19. 8.4 KPC Pharmaceuticals
  20. 8.4.1 KPC Pharmaceuticals Company Information
  21. 8.4.2 KPC Pharmaceuticals Business Overview
  22. 8.4.3 KPC Pharmaceuticals Artemether Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 KPC Pharmaceuticals Artemether Product Portfolio
  24. 8.4.5 KPC Pharmaceuticals Recent Developments
  25. 8.5 HOFON
  26. 8.5.1 HOFON Company Information
  27. 8.5.2 HOFON Business Overview
  28. 8.5.3 HOFON Artemether Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 HOFON Artemether Product Portfolio
  30. 8.5.5 HOFON Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Artemether Value Chain Analysis
  2. 9.1.1 Artemether Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Artemether Sales Mode & Process
  6. 9.2 Artemether Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Artemether Distributors
  9. 9.2.3 Artemether Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst